Atrás
Rango del Día
$20.15
$20.98
Rango de 52 Semanas
$6.50
$26.40
Volumen
1,454,726
Promedio 50D / 200D
$21.61
/
$16.52
Cierre Anterior
$21.41
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -5.8 | 0.3 |
| P/B | 3.2 | 2.9 |
| ROE % | -63.3 | 3.7 |
| Net Margin % | -142.9 | 3.8 |
| Rev Growth 5Y % | -10.4 | 10.0 |
| D/E | 0.2 | 0.2 |
Precio Objetivo de Analistas
Hold
$28.00
+38.3%
Low: $20.00
High: $35.00
EPS Futuro
-$3.81
Ingresos Est.
93 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$1.70
$0.09 – $4.24
|
970 M | 6 |
| FY2029 |
-$0.77
-$1.93 – -$0.04
|
490 M | 6 |
| FY2028 |
-$2.19
-$2.83 – -$1.43
|
220 M | 8 |
Puntos Clave
Revenue declined -10.39% annually over 5 years
Debt/Equity of 0.16 — conservative balance sheet
Negative free cash flow of -484.00M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 6.13%
Capital efficient — spends only 0.81% of revenue on capex
Crecimiento
Revenue Growth (5Y)
-10.39%
Revenue (1Y)-4.26%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-63.26%
ROIC-39.66%
Net Margin-142.91%
Op. Margin-156.28%
Seguridad
Debt / Equity
0.16
Current Ratio4.36
Interest Coverage-48.25
Valoración
P/E Ratio
-5.78
P/B Ratio3.23
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -4.26% | Revenue Growth (3Y) | 45.30% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -10.39% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 247.00M | Net Income (TTM) | -353.00M |
| ROE | -63.26% | ROA | -30.99% |
| Gross Margin | 95.95% | Operating Margin | -156.28% |
| Net Margin | -142.91% | Free Cash Flow (TTM) | -484.00M |
| ROIC | -39.66% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.16 | Current Ratio | 4.36 |
| Interest Coverage | -48.25 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -5.78 | P/B Ratio | 3.23 |
| P/S Ratio | 8.25 | PEG Ratio | -1.52 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 2.04B | Enterprise Value | 1.92B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 247.00M | 258.00M | 117.00M | 112.00M | 383.00M |
| Net Income | -353.00M | -283.00M | -307.00M | -267.00M | 53.00M |
| EPS (Diluted) | -3.29 | -3.14 | -4.15 | -3.71 | 0.71 |
| Gross Profit | 237.00M | 258.00M | 117.00M | 112.00M | 383.00M |
| Operating Income | -386.00M | -330.00M | -340.00M | -280.00M | 54.00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.14B | 1.15B | 1.10B | 1.35B | 1.59B |
| Total Liabilities | 508.00M | 665.00M | 633.00M | 688.00M | 750.45M |
| Shareholders' Equity | 631.00M | 485.00M | 462.00M | 657.00M | 841.45M |
| Total Debt | 99.00M | 60.00M | 11.00M | 120.00M | 121.99M |
| Cash & Equivalents | 222.00M | 150.00M | 127.00M | 206.00M | 147.91M |
| Current Assets | 1.01B | 1.02B | 831.00M | 1.07B | 1.26B |
| Current Liabilities | 231.00M | 226.00M | 184.00M | 193.00M | 166.08M |